Last reviewed · How we verify

NCT04950517: PAASD

Physical Activity and Cardiorespiratory Fitness in Adolescents With Autism Spectrum Disorder

Completed Last updated 26 June 2024
What this trial tests

trial in Autism Spectrum Disorder in 76 participants. Completed in 25 October 2023.

Timeline
18 November 2021
Primary endpoint
25 October 2023
25 October 2023

Quick facts

Lead sponsorUniversitaire Ziekenhuizen KU Leuven
StatusCompleted
Study typeOBSERVATIONAL
Enrollment76
Start date18 November 2021
Primary completion25 October 2023
Estimated completion25 October 2023
Sites2 locations across Belgium

Conditions studied

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

Adults 12 to 18, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to increase knowledge and insights with regard to physical activity behavior in adolescents with Autism Spectrum Disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04950517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing